69 related articles for article (PubMed ID: 20874022)
1. Interaction of cationic ultrasmall superparamagnetic iron oxide nanoparticles with human melanoma cells.
Cengelli F; Voinesco F; Juillerat-Jeanneret L
Nanomedicine (Lond); 2010 Sep; 5(7):1075-87. PubMed ID: 20874022
[TBL] [Abstract][Full Text] [Related]
2. Surface-functionalized ultrasmall superparamagnetic nanoparticles as magnetic delivery vectors for camptothecin.
Cengelli F; Grzyb JA; Montoro A; Hofmann H; Hanessian S; Juillerat-Jeanneret L
ChemMedChem; 2009 Jun; 4(6):988-97. PubMed ID: 19347834
[TBL] [Abstract][Full Text] [Related]
3. The internalization pathway, metabolic fate and biological effect of superparamagnetic iron oxide nanoparticles in the macrophage-like RAW264.7 cell.
Gu J; Xu H; Han Y; Dai W; Hao W; Wang C; Gu N; Xu H; Cao J
Sci China Life Sci; 2011 Sep; 54(9):793-805. PubMed ID: 21922429
[TBL] [Abstract][Full Text] [Related]
4. Development of functionalized superparamagnetic iron oxide nanoparticles for interaction with human cancer cells.
Petri-Fink A; Chastellain M; Juillerat-Jeanneret L; Ferrari A; Hofmann H
Biomaterials; 2005 May; 26(15):2685-94. PubMed ID: 15585272
[TBL] [Abstract][Full Text] [Related]
5. Uptake and inflammatory effects of nanoparticles in a human vascular endothelial cell line.
Kennedy IM; Wilson D; Barakat AI;
Res Rep Health Eff Inst; 2009 Jan; (136):3-32. PubMed ID: 19552347
[TBL] [Abstract][Full Text] [Related]
6. Modeling receptor-mediated endocytosis of polymer-functionalized iron oxide nanoparticles by human macrophages.
Lunov O; Zablotskii V; Syrovets T; Röcker C; Tron K; Nienhaus GU; Simmet T
Biomaterials; 2011 Jan; 32(2):547-55. PubMed ID: 20880574
[TBL] [Abstract][Full Text] [Related]
7. Interaction of functionalized superparamagnetic iron oxide nanoparticles with brain structures.
Cengelli F; Maysinger D; Tschudi-Monnet F; Montet X; Corot C; Petri-Fink A; Hofmann H; Juillerat-Jeanneret L
J Pharmacol Exp Ther; 2006 Jul; 318(1):108-16. PubMed ID: 16608917
[TBL] [Abstract][Full Text] [Related]
8. Methotrexate-modified superparamagnetic nanoparticles and their intracellular uptake into human cancer cells.
Kohler N; Sun C; Wang J; Zhang M
Langmuir; 2005 Sep; 21(19):8858-64. PubMed ID: 16142971
[TBL] [Abstract][Full Text] [Related]
9. D-mannose-modified iron oxide nanoparticles for stem cell labeling.
Horak D; Babic M; Jendelová P; Herynek V; Trchová M; Pientka Z; Pollert E; Hájek M; Syková E
Bioconjug Chem; 2007; 18(3):635-44. PubMed ID: 17370996
[TBL] [Abstract][Full Text] [Related]
10. Terfenadine-induced apoptosis in human melanoma cells is mediated through Ca2+ homeostasis modulation and tyrosine kinase activity, independently of H1 histamine receptors.
Jangi SM; Ruiz-Larrea MB; Nicolau-Galmés F; Andollo N; Arroyo-Berdugo Y; Ortega-Martínez I; Díaz-Pérez JL; Boyano MD
Carcinogenesis; 2008 Mar; 29(3):500-9. PubMed ID: 18174239
[TBL] [Abstract][Full Text] [Related]
11. Intracellular trafficking of superparamagnetic iron oxide nanoparticles conjugated with TAT peptide: 3-dimensional electron tomography analysis.
Nair BG; Fukuda T; Mizuki T; Hanajiri T; Maekawa T
Biochem Biophys Res Commun; 2012 May; 421(4):763-7. PubMed ID: 22546557
[TBL] [Abstract][Full Text] [Related]
12. Clathrin and caveolin-1 expression in primary pigmented rabbit conjunctival epithelial cells: role in PLGA nanoparticle endocytosis.
Qaddoumi MG; Gukasyan HJ; Davda J; Labhasetwar V; Kim KJ; Lee VH
Mol Vis; 2003 Oct; 9():559-68. PubMed ID: 14566223
[TBL] [Abstract][Full Text] [Related]
13. Inorganic metal hydroxide nanoparticles for targeted cellular uptake through clathrin-mediated endocytosis.
Oh JM; Choi SJ; Lee GE; Kim JE; Choy JH
Chem Asian J; 2009 Jan; 4(1):67-73. PubMed ID: 18988236
[TBL] [Abstract][Full Text] [Related]
14. Enhanced cell uptake of superparamagnetic iron oxide nanoparticles functionalized with dendritic guanidines.
Martin AL; Bernas LM; Rutt BK; Foster PJ; Gillies ER
Bioconjug Chem; 2008 Dec; 19(12):2375-84. PubMed ID: 19053308
[TBL] [Abstract][Full Text] [Related]
15. MRI detection of thrombin with aptamer functionalized superparamagnetic iron oxide nanoparticles.
Yigit MV; Mazumdar D; Lu Y
Bioconjug Chem; 2008 Feb; 19(2):412-7. PubMed ID: 18173225
[TBL] [Abstract][Full Text] [Related]
16. Ultrastructural and some functional changes in tumor cells treated with stabilized iron oxide nanoparticles.
Yurchenko OV; Todor IN; Khayetsky IK; Tregubova NA; Lukianova NY; Chekhun VF
Exp Oncol; 2010 Dec; 32(4):237-42. PubMed ID: 21270752
[TBL] [Abstract][Full Text] [Related]
17. The effect of the iron(III) chelator, desferrioxamine, on iron and transferrin uptake by the human malignant melanoma cell.
Richardson D; Ponka P; Baker E
Cancer Res; 1994 Feb; 54(3):685-9. PubMed ID: 8306330
[TBL] [Abstract][Full Text] [Related]
18. (Carboxymethyl)chitosan-modified superparamagnetic iron oxide nanoparticles for magnetic resonance imaging of stem cells.
Shi Z; Neoh KG; Kang ET; Shuter B; Wang SC; Poh C; Wang W
ACS Appl Mater Interfaces; 2009 Feb; 1(2):328-35. PubMed ID: 20353220
[TBL] [Abstract][Full Text] [Related]
19. Magnetic force microscopy of iron oxide nanoparticles and their cellular uptake.
Zhang Y; Yang M; Ozkan M; Ozkan CS
Biotechnol Prog; 2009; 25(4):923-8. PubMed ID: 19562741
[TBL] [Abstract][Full Text] [Related]
20. In vitro cancer cell imaging and therapy using transferrin-conjugated gold nanoparticles.
Li JL; Wang L; Liu XY; Zhang ZP; Guo HC; Liu WM; Tang SH
Cancer Lett; 2009 Feb; 274(2):319-26. PubMed ID: 18977071
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
